Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin + Interferon-beta-1b in RRMS (SWABIMS)
NCT00942591Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- May 2005
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in relapsing-remitting multiple sclerosis (RRMS), sponsored by Insel Gruppe. Started May 2005; status: completed.
02
Drugs
atorvastatin
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00942591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942591.